The 772-bed hospital’s strengths were considered for the rating affirmation, including its consistently favorable profitability margins.
TMH also faces some challenges, which were considered for the rating affirmation, such as increasing Medicaid exposure.
The outlook revision “reflects the sizable upcoming capital and associated construction risk with TMH’s plan to build a new patient tower on the main campus,” according to Moody’s.
More articles on healthcare finance:
10 hospital CFOs in the headlines this week
13 recent hospital outlook and rating actions
MedPAC makes 3 ‘two-midnight’ rule recommendations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit